Area under the curve (AUC) for CareStart and FST against the gold standard quantitative spectrophotometry at three thresholds (205, 30% and 40%) of G6PD activity.
Ongoing developments in myoelectric prosthesis control have provided prosthesis users with an assortment of control strategies that vary in reliability and performance. Many studies have focused on im